JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2751
TriMas Corp
TRS
$1.4B
| $2.25M | ﹤0.01% |
97,496
+6,557
| +7% | +$180K |
2013 Q2
27 quarters
|
|
|
HTBK
2752
DELISTED
Heritage Commerce
HTBK
| $2.25M | ﹤0.01% |
293,547
+36,131
| +14% | +$382K |
2016 Q4
13 quarters
|
|
2753
Olin
OLN
$1.85B
| $2.24M | ﹤0.01% |
191,993
-130,756
| -41% | -$1.98M |
2013 Q2
27 quarters
|
|
2754
CALL
AstraZeneca
AZN
$246B
| $2.23M | ﹤0.01% |
25,000
| – | – |
2018 Q3
6 quarters
|
|
|
BMTC
2755
DELISTED
Bryn Mawr Bank Corp
BMTC
| $2.23M | ﹤0.01% |
78,557
-2,108
| -3% | -$74K |
2016 Q2
15 quarters
|
|
2756
iShares Core 10+ Year USD Bond ETF
ILTB
$581M
| $2.23M | ﹤0.01% |
31,293
+2,002
| +7% | +$141K |
2014 Q3
22 quarters
|
|
2757
JPMorgan Ultra-Short Income ETF
JPST
$42.1B
| $2.23M | ﹤0.01% |
44,861
-42,563
| -49% | -$2.14M |
2017 Q2
11 quarters
|
|
2758
Caleres
CAL
$429M
| $2.23M | ﹤0.01% |
428,244
+299,775
| +233% | +$4.31M |
2013 Q2
27 quarters
|
|
2759
Element Solutions
ESI
$9.15B
| $2.22M | ﹤0.01% |
265,191
+177,688
| +203% | +$1.89M |
2015 Q4
17 quarters
|
|
|
RWDE
2760
DELISTED
Direxion MSCI Developed Over Emerging Markets ETF
RWDE
| $2.21M | ﹤0.01% |
+49,993
| New | +$2.64M |
2020 Q1
0 quarters
|
|
2761
Hecla Mining
HL
$11.6B
| $2.21M | ﹤0.01% |
1,216,433
+523,133
| +75% | +$1.45M |
2015 Q4
17 quarters
|
|
2762
Peoples Bancorp
PEBO
$1.32B
| $2.21M | ﹤0.01% |
99,770
-6,348
| -6% | -$189K |
2016 Q4
13 quarters
|
|
|
TDAY
2763
USA Today Co
TDAY
$1.08B
| $2.21M | ﹤0.01% |
1,493,721
+868,612
| +139% | +$4.29M |
2017 Q4
9 quarters
|
|
2764
McGrath RentCorp
MGRC
$2.9B
| $2.21M | ﹤0.01% |
42,114
+24,961
| +146% | +$1.75M |
2016 Q4
13 quarters
|
|
|
VSTO
2765
DELISTED
Vista Outdoor Inc.
VSTO
| $2.2M | ﹤0.01% |
249,481
+138,857
| +126% | +$1.06M |
2015 Q1
20 quarters
|
|
2766
iShares Expanded Tech Sector ETF
IGM
$11.8B
| $2.19M | ﹤0.01% |
62,082
-102
| -0.2% | -$4.09K |
2013 Q2
27 quarters
|
|
2767
Oceaneering
OII
$4.47B
| $2.19M | ﹤0.01% |
744,612
+529,166
| +246% | +$5.52M |
2013 Q2
27 quarters
|
|
2768
Antero Midstream
AM
$10B
| $2.19M | ﹤0.01% |
1,040,484
-68,069
| -6% | -$325K |
2017 Q2
11 quarters
|
|
2769
NVE Corp
NVEC
$569M
| $2.18M | ﹤0.01% |
41,939
-13,938
| -25% | -$911K |
2017 Q4
9 quarters
|
|
2770
PUT
Charter Communications
CHTR
$12.5B
| $2.18M | ﹤0.01% |
5,000
-17,500
| -78% | -$8.56M |
2019 Q1
4 quarters
|
|
2771
Fidelity MSCI Health Care Index ETF
FHLC
$3.41B
| $2.18M | ﹤0.01% |
50,718
+22,102
| +77% | +$1.05M |
2017 Q3
10 quarters
|
|
2772
PUT
Alnylam Pharmaceuticals
ALNY
$30.1B
| $2.18M | ﹤0.01% |
+20,000
| New | +$2.31M |
2020 Q1
0 quarters
|
|
|
SRTA
2773
Strata Critical Medical Inc
SRTA
$423M
| $2.17M | ﹤0.01% |
+224,965
| New | +$2.23M |
2020 Q1
0 quarters
|
|
|
FNHC
2774
DELISTED
FedNat Holding Company Common Stock
FNHC
| $2.17M | ﹤0.01% |
189,114
-26,292
| -12% | -$368K |
2016 Q4
13 quarters
|
|
2775
PJT Partners
PJT
$3.55B
| $2.17M | ﹤0.01% |
49,983
+35,126
| +236% | +$1.54M |
2015 Q4
17 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.